Back
Bristol-Myers Squibb Vs. Eli Lilly and Industry Stock Comparison
Buy
68
BMY
Bristol-Myers Squibb
Last Price:
62.01
Seasonality Move:
4.69%
Buy
79
LLY
Eli Lilly and
Last Price:
557.11
Seasonality Move:
2.72%
Buy
68
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $62.02. The Score for BMY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
79
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $557.11. The Score for LLY is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $62.02
The current trend is relatively stagnant and BMY is experiencing slight selling pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $557.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing slight buying pressure.
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 50.24 | Buy |
| Chaikin Money Flow: | -2162594 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.92 - 62.18) | Buy |
| Bollinger Bands (100): | (61.83 - 67.61) | Sell |
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20.99 | Buy |
| Relative Strength Index (14 RSI): | 72.99 | Buy |
| Chaikin Money Flow: | 495660 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (481.71 - 562.53) | Buy |
| Bollinger Bands (100): | (405.01 - 504.93) | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.93 | Buy |
| 20-day SMA: | 61.58 | Buy |
| 50-day SMA: | 62.42 | Sell |
| 200-day SMA: | 68.62 | Sell |
| 8-day EMA: | 61.97 | Buy |
| 20-day EMA: | 61.89 | Buy |
| 50-day EMA: | 62.65 | Sell |
| 200-day EMA: | 66.81 | Sell |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 552.77 | Buy |
| 20-day SMA: | 539.62 | Buy |
| 50-day SMA: | 488.62 | Buy |
| 200-day SMA: | 401.13 | Buy |
| 8-day EMA: | 551.56 | Buy |
| 20-day EMA: | 534.53 | Buy |
| 50-day EMA: | 498.67 | Buy |
| 200-day EMA: | 417.35 | Buy |
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.12 per share, and an increase next year of $0.41 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.05 per share, an increase this year of $1.87 per share, and an increase next year of $2.95 per share.
Bristol-Myers Squibb Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eli Lilly and Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||